HIGH-DOSE MELPHALAN, MISONIDAZOLE, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA - A PHASE-I STUDY

被引：10
|
作者：
SPITZER, TR [1 ]
LAZARUS, HM [1 ]
CREGER, RJ [1 ]
BERGER, NA [1 ]
机构：
[1] CASE WESTERN RESERVE UNIV,UNIV HOSP CLEVELAND,IRELAND CANCER CTR,DEPT MED,CLEVELAND,OH 44106
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 02期
关键词：
D O I：
10.1097/00000421-198904000-00012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：145 / 151
页数：7
相关论文
共 50 条
  • [21] TREATMENT OF EWINGS-SARCOMA INCLUDING HIGH-DOSE MELPHALAN WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GARWICZ, S
    KLINISCHE PADIATRIE, 1983, 195 (05): : 376 - 376
  • [22] TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    CORNBLEET, MA
    MCELWAIN, TJ
    KUMAR, PJ
    FILSHIE, J
    SELBY, P
    CARTER, RL
    HEDLEY, DW
    CLARK, ML
    MILLAR, JL
    BRITISH JOURNAL OF CANCER, 1983, 48 (03) : 329 - 334
  • [23] HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK MYELOMA
    HAROUSSEAU, JL
    MILPIED, N
    GARAND, R
    BOURHIS, JH
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (04) : 493 - 493
  • [24] PHASE-I STUDY OF HIGH-DOSE MITOMYCIN-C (HDMM) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN REFRACTORY BREAST-CARCINOMA
    SCHELL, FC
    DISTEFANO, A
    SPITZER, G
    DICKE, K
    BLUMENSCHEIN, GR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 144 - 144
  • [25] HIGH-DOSE N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE (THIOTEPA) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - PHASE-I STUDIES
    WOLFF, SN
    HERZIG, RH
    FAY, JW
    LEMAISTRE, CF
    BROWN, RA
    FREILAHR, D
    STRANJORD, S
    GIANNONE, L
    COCCIA, P
    WEICK, JL
    ROTHMAN, SA
    KRUPP, KR
    LOWDER, J
    BOLWELL, B
    HERZIG, GP
    SEMINARS IN ONCOLOGY, 1990, 17 (01) : 2 - 6
  • [26] A PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE AND ESCALATING DOSES OF CARBOPLATIN WITH AUTOLOGOUS BONE-MARROW SUPPORT
    ELIAS, AD
    AYASH, LJ
    EDER, JP
    WHEELER, C
    DEARY, J
    WEISSMAN, L
    SCHRYBER, S
    HUNT, M
    CRITCHLOW, J
    SCHNIPPER, L
    FREI, E
    ANTMAN, KH
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) : 320 - 327
  • [27] TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION - PRELIMINARY-RESULTS - PHASE-I STUDY
    THOMAS, MR
    ROBINSON, WA
    GLODE, LM
    DANTAS, ME
    KOEPPLER, H
    MORTON, N
    SUTHERLAND, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06): : 611 - 622
  • [28] HIGH-DOSE THIOTEPA WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC MALIGNANT-MELANOMA - RESULTS OF PHASE-I AND PHASE-II STUDIES OF THE NORTH-AMERICAN BONE-MARROW TRANSPLANTATION GROUP
    WOLFF, SN
    HERZIG, RH
    FAY, JW
    LEMAISTRE, CF
    FREILAHR, D
    LOWDER, J
    BOLWELL, B
    GIANNONE, L
    HERZIG, GP
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) : 245 - 249
  • [29] HIGH-DOSE BUSULFAN (BU) WITH AUTOLOGOUS BONE-MARROW SUPPORT (ABMS) - A PHASE-I TRIAL
    OLSEN, GA
    GOCKERMAN, JP
    WALSH, B
    WAY, T
    AVERY, S
    REMINE, S
    GILBERT, C
    SMITH, C
    SEIGLER, HF
    BAST, RC
    PETERS, WP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 236 - 236
  • [30] HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION IN PREVIOUSLY UNTREATED MYELOMA
    CUNNINGHAM, D
    PAZARES, L
    MILAN, S
    POWLES, R
    NICOLSON, M
    HICKISH, T
    SELBY, P
    TRELEAVAN, J
    VINER, C
    MALPAS, J
    SLEVIN, M
    FINDLAY, M
    RAYMOND, J
    GORE, ME
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 759 - 763
12345